Figure 1: Surface CCR3 and CCR5 expression as assessed by immunofluorescence in control and IL-1β- treated RIN-5AH β-like cells. IL-1β significantly down-regulated CCR3 membrane expression at 8 and 24 hours. Statistical significance was obtained for CCR5 at 4 and 24 hours.